search Created with Sketch.
search Created with Sketch.

Advertisement

Interruptions and Opportunities in Drug Development and Access

April 6, 2020

Neal Bhatia, MD, FAAD; Alison Ehrlich, MD; and Peter Pitts

Peter Pitts, Former Associate Commissioner at FDA and co-founder of Center for Medicine in the Public Interest speaks with Dr. Neal Bhatia about access to drugs for fighting COVID-19 and the FDA's ability to fast-track treatments and vaccines in a time of crisis. Alison Ehrlich, MD discusses the use of hydroxychloroquine in dermatology and strategies to protect patient access.

Advertisement

Podcast

Interested in listening to this video in audio format?

Listen to the coping with Covid-19 Podcast

Advertisement